JP2002521334A5 - - Google Patents

Download PDF

Info

Publication number
JP2002521334A5
JP2002521334A5 JP2000560893A JP2000560893A JP2002521334A5 JP 2002521334 A5 JP2002521334 A5 JP 2002521334A5 JP 2000560893 A JP2000560893 A JP 2000560893A JP 2000560893 A JP2000560893 A JP 2000560893A JP 2002521334 A5 JP2002521334 A5 JP 2002521334A5
Authority
JP
Japan
Prior art keywords
alkyl
branched
linear
cyclic
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2000560893A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002521334A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/012398 external-priority patent/WO2000004900A1/en
Publication of JP2002521334A publication Critical patent/JP2002521334A/ja
Publication of JP2002521334A5 publication Critical patent/JP2002521334A5/ja
Abandoned legal-status Critical Current

Links

JP2000560893A 1998-07-20 1999-07-20 置換ベンズイミダゾール抗ウィルス剤 Abandoned JP2002521334A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9338798P 1998-07-20 1998-07-20
US60/093,387 1998-07-20
PCT/US1999/012398 WO2000004900A1 (en) 1998-07-20 1999-07-20 Substituted benzimidazole antiviral agents

Publications (2)

Publication Number Publication Date
JP2002521334A JP2002521334A (ja) 2002-07-16
JP2002521334A5 true JP2002521334A5 (enExample) 2006-08-17

Family

ID=22238648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000560893A Abandoned JP2002521334A (ja) 1998-07-20 1999-07-20 置換ベンズイミダゾール抗ウィルス剤

Country Status (6)

Country Link
US (2) US6908936B2 (enExample)
EP (1) EP1098644A1 (enExample)
JP (1) JP2002521334A (enExample)
AU (1) AU741946B2 (enExample)
CA (1) CA2338147A1 (enExample)
WO (1) WO2000004900A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201789A3 (en) 1999-06-28 2003-12-29 Janssen Pharmaceutica Nv Respiratory syncytial virus replication inhibitors
ATE457177T1 (de) * 2000-05-03 2010-02-15 Medimmune Llc Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe
US6489338B2 (en) * 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US6774134B2 (en) 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
US7030150B2 (en) 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
TW200501985A (en) * 2002-07-25 2005-01-16 Medimmune Inc Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
US7157471B2 (en) * 2003-08-25 2007-01-02 Boehringer Ingelheim International Gmbh Haloalkyl- and piperidine-substituted benzimidazole-derivatives
US7323567B2 (en) 2003-10-30 2008-01-29 Boehringer Ingelheim (Canada) Ltd. RSV polymerase inhibitors
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0501964D0 (en) * 2005-01-31 2005-03-09 Arrow Therapeutics Ltd Chemical compounds
US8039616B2 (en) 2005-09-19 2011-10-18 Astrazeneca Ab Benzodiazepine derivatives for treating hepatitis C infection
GB0520475D0 (en) * 2005-10-07 2005-11-16 Arrow Therapeutics Ltd Chemical compounds
ATE508125T1 (de) * 2006-01-11 2011-05-15 Arrow Therapeutics Ltd Triazoloanilinopyrimidinderivate zur verwendung als antivirale mittel
AP2707A (en) * 2007-08-27 2013-07-29 Siga Technologies Inc Antiviral drugs for treatment of arenavirus infection
WO2009062874A2 (en) * 2007-11-15 2009-05-22 F. Hoffmann-La Roche Ag Benzimidazole derivatives and their use as fxr agonists
RU2407738C1 (ru) * 2009-07-03 2010-12-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Противовирусный активный компонент, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний
CN105793265B (zh) 2013-12-10 2018-02-13 山东丹红制药有限公司 作为抗病毒剂的咪唑衍生物及其制药用途
EP3305790B1 (en) 2015-06-08 2020-08-05 Shangdong Danhong Pharmaceutical Co., Ltd. Method for preparing imidazole derivative and intermediate thereof and crystal form
CN105820156A (zh) * 2016-04-21 2016-08-03 广东工业大学 苯并三氮唑基苯并咪唑啉及其制备方法和应用
GB201711704D0 (en) * 2017-07-20 2017-09-06 Reviral Ltd Pharmaceutical compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3394141A (en) 1965-11-12 1968-07-23 Fabio Sparatore Z-benzyaminobenzimidazoles
US4324794A (en) * 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
NO155805C (no) 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
US5256668A (en) 1993-03-17 1993-10-26 American Home Products Corporation Aminopyrimidine derivatives as antiviral agents for respiratory syncytial virus
CA2197393A1 (en) 1996-02-13 1997-08-14 Yakov Gluzman (Deceased) Triazine containing anionic compounds useful as antiviral agents
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents

Similar Documents

Publication Publication Date Title
JP2002521334A5 (enExample)
JP2001525411A5 (enExample)
JP2004516314A5 (enExample)
KR950003295A (ko) 트리시클릭 디아제핀 바조프레신 길항질 및 옥시토신 길항질, 및 이의 제조 방법
JP2003501474A5 (enExample)
JP2002502874A5 (enExample)
JP2010507639A5 (enExample)
RU2002131941A (ru) 3-азот-6,7-дикислородсодержащие стероиды и их применение
JP2001526218A5 (enExample)
KR920008006A (ko) 류코트리엔 길항제로서의 불포화 하이드록시 알킬퀴놀린산
JP2008510691A5 (enExample)
JP2006500394A5 (enExample)
JP2006527776A5 (enExample)
EA200200898A1 (ru) Способ получения циталопрама
EP1108428A3 (en) Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof
JP2004534788A5 (enExample)
JP2001513567A5 (enExample)
RU96111027A (ru) Трициклические 5,6-дигидро-9h-пиразоло [3,4-c]-1,2,4-триазоло [4,3-a]пиридины
BR9509608A (pt) Inibidores de proliferação de células de músculo liso
JP2002522385A5 (enExample)
KR910015580A (ko) 신규 콜린에스테라제 억제제로서의 삼환-일환식 아민
RU2001114213A (ru) Циклоалкилзамещенное производное аминометилпирролидина
JPH1036365A5 (enExample)
JP2001518468A5 (enExample)
JP2002526550A5 (enExample)